CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

March 1, 2023 · earnings

TBPH earnings: a negative outcome, -7.0%

On March 1, 2023, Theravance Biopharma, Inc. reached its earnings. The result was a negative outcome, and the stock moved -7.0% in the window around the event. It had already run -7.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$10.80
1d before
$10.04
Event day
$10.11
1d after
$10.15
5d after

Pre-catalyst setup

-7.1%
30-day run-up
3454%
30-day volatility
1.7×
volume spike